Description
Tenoxicam Impurity 1 is an impurity of tenoxicam preparation. It is used as building block of pharmaceutical and organic synthesis.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Tenoxicam Impurity 1 is an impurity of tenoxicam preparation. It is used as building block of pharmaceutical and organic synthesis.
| Cas No. | 98827-44-2 |
|---|---|
| Purity | ≥98% |
| Formula | C8H7NO5S2 |
| Formula Wt. | 261.27 |
| Chemical Name | (4-hydroxy-3-methoxycarbonyl-2H- thieno(2,3,e)-1,2-thiazine-1,1-dioxide) |
| IUPAC Name | Methyl 4-hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate 1,1-dioxide |
| Synonym | Methyl 4-Hydroxy-2H-thieno[2,3-e][1,2]thiazine-3-carboxylate-1,1-dioxide |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
RET, EGFR, VEGFR2 inhibitor.
p110δ and p110γ PI3K inhibitor.
5-HT2A and TRPV1 antagonist, potential α1-adre...
c-Raf, RET, VEGFR1 inhibitor, potential HMT inh...
GABA-A agonist, NMDA antagonist, voltage-gated ...
Steroid found in myrrh; FXR antagonist.
Snake venom cardiotoxin found in Naja naja atra...
Alters intracellular glutathione levels.
Nucleoside (guanosine) analog; DNA chain termin...
β-lactamase inhibitor.
Benzisoxazole phenylethanone; D2 and 5-HT2A ant...
Antimicrobial peptide found in amphibians.
Potential AhR binding agent.
BHA derivative.
Selective inhibitor of LRRK2.
Peptide; NMDA partial agonist.
Endogenous opioid peptide; δOR and μOR agonis...
CDK4/6 inhibitor.
Pyrimidine nucleoside (cytidine) analog; DNA ch...
GSK-3β inhibitor.